167 related articles for article (PubMed ID: 3576464)
1. [Use of hemosorption in the treatment of patients with chronic liver diseases].
Radchenko VG; Litvinov AS; Vinogradova GL
Ter Arkh; 1987; 59(2):118-21. PubMed ID: 3576464
[TBL] [Abstract][Full Text] [Related]
2. [Effect of hemosorption on collagen metabolic indices in chronic liver diseases].
Sitnikov VA; Sharaev PN
Vrach Delo; 1987 Sep; (9):37-40. PubMed ID: 3424770
[No Abstract] [Full Text] [Related]
3. [Hemosorption in the complex treatment of liver and biliary tract diseases].
Dubrovskiĭ AK; Belov NN; Kondrashev VF
Khirurgiia (Mosk); 1979 Apr; (4):69-73. PubMed ID: 459299
[No Abstract] [Full Text] [Related]
4. [Effect of hemosorption on the clinical course of chronic liver diseases].
Kurdybaĭlo FV; Kolmakov VN; Nechaev IV; Potapova IV; Radchenko VG
Vrach Delo; 1988 Jul; (7):60-3. PubMed ID: 3188472
[No Abstract] [Full Text] [Related]
5. [Lecithin-cholesterol-acyltransferase activity in chronic liver diseases].
Gaskina TK; Dolgov AV; Kurilovich SA
Vopr Med Khim; 1987; 33(4):96-9. PubMed ID: 3660750
[TBL] [Abstract][Full Text] [Related]
6. [The interferon therapy of patients with chronic viral hepatitis: the factors affecting the treatment results].
Kokoreva LN; Zmyzgova AV; Shalygina NB
Ter Arkh; 1996; 68(2):10-4. PubMed ID: 8771646
[TBL] [Abstract][Full Text] [Related]
7. [Long-term prognosis of chronic B and C viral hepatitis].
Ohlen J; Liegl JM; Selmair H
Leber Magen Darm; 1995 Sep; 25(5):205-10. PubMed ID: 7500807
[TBL] [Abstract][Full Text] [Related]
8. [Effect of hemosorption on blood insulin levels in patients with chronic liver failure].
Sitnikov VA; Pozdeev SR; Bryndin VV; Zelenin AA
Vrach Delo; 1983 Aug; (8):91-4. PubMed ID: 6356596
[No Abstract] [Full Text] [Related]
9. Variations in humoral and cellular immunologic changes in relation to the evolutive stage of chronic active liver disease.
Banciu T; Argan P; Suşan L; Ocică I; Perţa D
Med Interne; 1987; 25(1):25-30. PubMed ID: 3495858
[TBL] [Abstract][Full Text] [Related]
10. [Effect of carsil and legalon in treating chronic liver diseases].
Brailski Kh; Chernev K; Etŭrska M; Donov M; Velev G
Vutr Boles; 1986; 25(3):43-9. PubMed ID: 3765578
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte subpopulations at the site of "piecemeal" necrosis in end stage chronic liver diseases and rejecting liver allografts in cyclosporine-treated patients.
Si L; Whiteside TL; Van Thiel DH; Rabin BS
Lab Invest; 1984 Mar; 50(3):341-7. PubMed ID: 6366363
[TBL] [Abstract][Full Text] [Related]
12. [Dynamics of the mental disturbances in primary biliary liver cirrhosis with allowance for a hemosorption procedure].
Korkina MV; Lopukhin IuM; Molodenkov MN; Tsivil'ko MA; Kareva MA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(11):1694-8. PubMed ID: 7324672
[TBL] [Abstract][Full Text] [Related]
13. Circulating ICAM-1 (sCD54) and LFA-3 (sCD58) in chronic hepatitis B--a longitudinal study in patients treated with interferon-alpha.
Knolle PA; Eckardt AJ; Protzer-Knolle U; Schirmacher P; Dienes HP; Meyer zum Büschenfelde KH; Gerken G
Z Gastroenterol; 1997 Jun; 35(6):459-67. PubMed ID: 9231990
[TBL] [Abstract][Full Text] [Related]
14. [The enhancement of treatment efficacy in chronic liver failure by using hemoperfusion across donor hepatocytes and spleen fragments].
Onishchenko NA; Bazieva FKh; Orzhekhovskaia IG; Toshchakov VIu; Polosina OV; Danilov MA; Suskova VS
Ter Arkh; 1995; 67(2):6-9. PubMed ID: 7725264
[TBL] [Abstract][Full Text] [Related]
15. [Clinico-diagnostic significance of the determination of bile acids in chronic liver diseases].
Andreuzzi B; Vai C; Santese R; Andreuzzi P; Cantoni L
Minerva Med; 1984 Mar; 75(13):749-56. PubMed ID: 6717831
[TBL] [Abstract][Full Text] [Related]
16. [Principles of the treatment of patients with chronic liver diseases].
Ivashkin VT; Khazanov AI; Ivlev AS; Rumiantsev ON; Vasil'ev AP; Gerasimov GM
Sov Med; 1991; (12):66-9. PubMed ID: 1780789
[No Abstract] [Full Text] [Related]
17. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
[TBL] [Abstract][Full Text] [Related]
18. [The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease].
Kwon JH; Park ST; Kim GD; You CR; Kim JD; Woo HY; Jang JW; Kim CW; Bae SH; Choi JY; Yoon SK
Korean J Hepatol; 2009 Mar; 15(1):59-69. PubMed ID: 19346786
[TBL] [Abstract][Full Text] [Related]
19. [The influence of diet therapy on the blood serum beta-lipoprotein content in patients with atherosclerosis, obesity and chronic liver diseases].
Loranskaia TI
Vopr Pitan; 1966; 25(1):61-5. PubMed ID: 5966858
[No Abstract] [Full Text] [Related]
20. Genotype B hepatitis B virus is associated with severe icteric flare-up of chronic hepatitis B virus infection in Hong Kong.
Chan HL; Tsang SW; Wong ML; Tse CH; Leung NW; Chan FK; Sung JJ
Am J Gastroenterol; 2002 Oct; 97(10):2629-33. PubMed ID: 12385451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
